AKAP8L

AKAP8L is a nuclear–cytoplasmic shuttling protein that integrates RNA export, mRNA stability, mTORC1 signaling, and PKA anchoring to regulate cell growth, proliferation, and differentiation. It binds RNA helicase A (RHA) through its C-terminal nuclear transport domain and synergizes with RHA to promote constitutive transport element (CTE)-dependent nuclear export of unspliced retroviral mRNA, with a nuclear export signal required for this activity (PMID:10748171, PMID:11402034). AKAP8L interacts with mTORC1 via its N-terminal region in the cytoplasm to promote mTORC1-dependent translation and cell growth, while anchoring PKA regulatory subunit Iα; loss of AKAP8L impairs proliferation and mTORC1-regulated processes, an interaction independently validated in microglia where it modulates autophagic flux and neuroinflammation (PMID:32312749, PMID:39033121). AKAP8L also functions as an RNA-binding protein that stabilizes SCD1 mRNA in an IGF2BP1-dependent manner and is required for commitment of hematopoietic stem cells to the erythroid lineage (PMID:36522343, PMID:32457162).

1. 2000 High

   The identification of AKAP8L (HAP95/NAKAP95) as a nuclear shuttling protein that binds RNA helicase A and promotes CTE-dependent gene expression established it as a participant in unspliced mRNA nuclear export, a function previously attributed only to RHA and its known cofactors.

   Evidence Yeast two-hybrid, co-immunoprecipitation, CTE reporter assay, and nuclear export assay in mammalian cells

   PMID:10697960 PMID:10748171

   Open questions at the time

   • Endogenous mRNA targets of AKAP8L-dependent export were not identified
   • No structural basis for the HAP95–RHA interaction
   • Whether AKAP8L functions independently of RHA was untested
2. 2001 High

   Systematic domain mapping revealed that both the RHA-binding domain and a novel nuclear export signal are required for CTE transactivation, establishing the minimal functional architecture of AKAP8L in mRNA export.

   Evidence Truncation/deletion mutagenesis with CTE reporter assays and co-immunoprecipitation

   PMID:11402034

   Open questions at the time

   • Whether the NES is recognized by CRM1 or another export receptor was not determined
   • Physiological mRNA cargo beyond CTE-containing reporters remained unknown
3. 2014 Medium

   Demonstrating that AKAP8L associates with HIV-1 Pol and modulates tRNALys3 annealing by transiently inhibiting RHA expanded the functional picture from mRNA export to viral RNA packaging.

   Evidence Co-immunoprecipitation, siRNA knockdown, and in vitro reconstitution with purified GST-HAP95

   PMID:25034436

   Open questions at the time

   • In vivo relevance for HIV replication was not established with infectious virus
   • Whether this reflects a broader RNA chaperoning function of AKAP8L is unclear
4. 2020 High

   Discovery that AKAP8L binds mTORC1 through its N-terminal domain to promote translation, cell growth, and proliferation — and anchors PKA RIα — revealed a cytoplasmic signaling scaffold function distinct from its nuclear RNA export role.

   Evidence Co-immunoprecipitation, domain deletion mutagenesis with rescue, translation and proliferation assays in mammalian cells

   PMID:32312749

   Open questions at the time

   • How AKAP8L partitioning between nucleus and cytoplasm is regulated remains unknown
   • Whether PKA anchoring and mTORC1 binding are coordinated or independent functions was not resolved
   • Direct PKA phosphorylation of mTORC1 components via AKAP8L scaffolding was not tested
5. 2020 Medium

   Loss-of-function studies showing that AKAP8L knockdown blocks erythroid commitment of hematopoietic stem cells linked its growth-promoting functions to a specific developmental context.

   Evidence shRNA/siRNA knockdown with flow cytometry-based differentiation and colony-forming assays in primary human hematopoietic cells

   PMID:32457162

   Open questions at the time

   • The molecular pathway through which AKAP8L promotes erythroid commitment was not delineated
   • Whether mTORC1 or PKA signaling mediates this differentiation phenotype is unknown
6. 2022 Medium

   Identification of AKAP8L as an RNA-binding protein that stabilizes SCD1 mRNA through IGF2BP1 established a post-transcriptional gene regulation function with implications for cancer cell stemness.

   Evidence RNA immunoprecipitation, co-immunoprecipitation, combinatorial knockdown/overexpression in gastric cancer cells with in vivo xenograft validation

   PMID:36522343

   Open questions at the time

   • The full repertoire of AKAP8L-bound mRNAs beyond SCD1 is uncharacterized
   • Whether AKAP8L directly contacts RNA or acts solely through IGF2BP1 was not resolved
   • Relationship between mRNA stabilization and mTORC1 scaffolding functions is unexplored
7. 2024 Medium

   Confirmation of the AKAP8L–mTORC1 interaction in microglia by proximity ligation assay, together with in vivo knockdown rescuing autophagic flux and cognitive deficits in diabetic mice, validated the mTORC1 scaffolding role in a disease-relevant physiological setting.

   Evidence Co-immunoprecipitation, proximity ligation assay, siRNA knockdown in microglia, Morris water maze in STZ-diabetic mice

   PMID:39033121

   Open questions at the time

   • Whether AKAP8L regulation of mTORC1 in microglia involves PKA anchoring was not addressed
   • Mechanism by which high glucose upregulates AKAP8L is unknown

• How AKAP8L coordinates its nuclear (RNA export, chromatin interaction) and cytoplasmic (mTORC1 scaffolding, PKA anchoring, mRNA stabilization) functions, and what signals regulate its nucleocytoplasmic distribution, remain central open questions.
• No structural model of AKAP8L or its complexes exists
• The complete RNA-binding specificity and transcriptome-wide target set are undefined
• Whether chromatin-modifying complex interactions (DPY30/H3K4 HMT) have functional consequences is untested